Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 22Recruiting 10Unknown 7Terminated 4Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 10Tumor-Agnostic 8Thoracic 8Genitourinary 7Breast 5Dermatologic 4CNS 4Sarcoma 3Plasma cell 3Gynecologic 3Lymphoid 2Other 1Head & Neck 1Endocrine 1

Conditions

Melanoma 3Urinary Bladder Neoplasms 1Testicular Neoplasms 1Skin Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Neoplasms 1

Interventions

pembrolizumab 58Ipilimumab 53Cyclophosphamide 53Nivolumab 45aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 19dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11spartalizumab 10Filgrastim 10Dacarbazine 10cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Blood Specimen Collection × Dermatologic × Clear all
NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Mayo Clinic

Terminated
13 enrolled
DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT02414750 2022-11-30

REPOSIT

Netherlands Working Group on Immunotherapy of Oncology

Phase 2 Terminated
78 enrolled
Dermatologic

Melanoma

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

M.D. Anderson Cancer Center

Terminated
131 enrolled
Dermatologic

Melanoma, Neoplasms

NCT03603587 2020-03-05

BACCHUS

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated
1 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡